Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 3 of 3 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/17/21
End: 02/23/23
Due: 02/23/24
Phase: N/A
Priority: Normal
Start: 09/01/21
End: 05/29/24
Due: 05/29/25
Phase: N/A
Priority: Normal
Start: 02/03/25
End: 07/30/29
Due: 07/30/30
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia | NCT04659122 | Airway Therapeutics, Inc. | user2@example.com | None | 2021-08-17 | 2023-02-23 | 2024-02-23 | - | - | 2025-07-14 |
| A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD) | NCT04662151 | Airway Therapeutics, Inc. | user2@example.com | None | 2021-09-01 | 2024-05-29 | 2025-05-29 | - | - | 2025-07-14 |
| Efficacy of Zelpultide Alfa in Preterm Neonates at High Risk of Developing Bronchopulmonary Dysplasia (BPD) | NCT06897839 | Airway Therapeutics, Inc. | user2@example.com | None | 2025-02-03 | 2029-07-30 | 2030-07-30 | - | - | 2025-07-14 |